| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $304.1M | +24.7% |
| Cost of Revenue | $259.6M | +39.7% |
| Gross Profit | $44.5M | -23.3% |
| R&D Expense | $6.1M | +23.1% |
| SG&A Expense | $71.4M | +4.2% |
| Operating Income | -$42.2M | -171.4% |
| Interest Expense | $13.5M | +26.0% |
| Pre-tax Income | -$116.3M | -319.2% |
| Income Tax | -$2.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.7M | +11.3% |
| Accounts Receivable | $21.9M | -32.4% |
| Inventory | $2.2M | +47.7% |
| Current Assets | $125.9M | +15.2% |
| Total Assets | $292.6M | +7.9% |
| Current Liabilities | $149.3M | +33.3% |
| Long-term Debt | $125.7M | +42.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.3M | -1509.3% |
| Capital Expenditures | $6.4M | +13.9% |
| Investing Cash Flow | -$7.2M | +13.5% |
| Financing Cash Flow | $43.7M | +382.5% |
| Free Cash Flow | -$23.7M | -441.1% |
| -315.6% |
| Net Income | -$114.3M | -319.3% |
| EPS (Basic) | -$2.35 | -221.9% |
| EPS (Diluted) | -$2.35 | -221.9% |
| Total Liabilities |
| $344.5M |
| +57.7% |
| Stockholders' Equity | -$188.7M | -333.7% |